Silverfin false false 30/09/2024 01/10/2023 30/09/2024 J J Cowie 12/08/2015 L Moranzoni 12/08/2015 R N Saunders 04/03/2025 26 March 2025 The principal activity of the company is the provision of dental courses. 09730108 2024-09-30 09730108 bus:Director1 2024-09-30 09730108 bus:Director2 2024-09-30 09730108 bus:Director3 2024-09-30 09730108 2023-09-30 09730108 core:CurrentFinancialInstruments 2024-09-30 09730108 core:CurrentFinancialInstruments 2023-09-30 09730108 core:ShareCapital 2024-09-30 09730108 core:ShareCapital 2023-09-30 09730108 core:RetainedEarningsAccumulatedLosses 2024-09-30 09730108 core:RetainedEarningsAccumulatedLosses 2023-09-30 09730108 bus:OrdinaryShareClass1 2024-09-30 09730108 2023-10-01 2024-09-30 09730108 bus:FilletedAccounts 2023-10-01 2024-09-30 09730108 bus:SmallEntities 2023-10-01 2024-09-30 09730108 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 09730108 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 09730108 bus:Director1 2023-10-01 2024-09-30 09730108 bus:Director2 2023-10-01 2024-09-30 09730108 bus:Director3 2023-10-01 2024-09-30 09730108 2022-10-01 2023-09-30 09730108 bus:OrdinaryShareClass1 2023-10-01 2024-09-30 09730108 bus:OrdinaryShareClass1 2022-10-01 2023-09-30 iso4217:GBP xbrli:pure xbrli:shares

Company No: 09730108 (England and Wales)

CONTEMPORARY ENDODONTICS LIMITED

Unaudited Financial Statements
For the financial year ended 30 September 2024
Pages for filing with the registrar

CONTEMPORARY ENDODONTICS LIMITED

Unaudited Financial Statements

For the financial year ended 30 September 2024

Contents

CONTEMPORARY ENDODONTICS LIMITED

BALANCE SHEET

As at 30 September 2024
CONTEMPORARY ENDODONTICS LIMITED

BALANCE SHEET (continued)

As at 30 September 2024
Note 2024 2023
£ £
Current assets
Stocks 3 3,640 0
Cash at bank and in hand 573 0
4,213 0
Creditors: amounts falling due within one year 4 ( 13,140) ( 5,459)
Net current liabilities (8,927) (5,459)
Total assets less current liabilities (8,927) (5,459)
Net liabilities ( 8,927) ( 5,459)
Capital and reserves
Called-up share capital 5 1,000 1,000
Profit and loss account ( 9,927 ) ( 6,459 )
Total shareholders' deficit ( 8,927) ( 5,459)

For the financial year ending 30 September 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

These financial statements have been prepared in accordance with the provisions of FRS 102 Section 1A – small entities. The financial statements of Contemporary Endodontics Limited (registered number: 09730108) were approved and authorised for issue by the Board of Directors on 26 March 2025. They were signed on its behalf by:

J J Cowie
Director
L Moranzoni
Director
CONTEMPORARY ENDODONTICS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 September 2024
CONTEMPORARY ENDODONTICS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 September 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Contemporary Endodontics Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Lowin House, Tregolls Road, Truro, TR1 2NA, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of value added tax, returns, rebates and discounts and after eliminating sales within the company.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Taxation

Current tax
Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current corporation tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax
Deferred tax is recognised on all timing differences at the balance sheet date unless indicated below. Timing differences are differences between taxable profits and the results as stated in the profit and loss account and other comprehensive income. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost is calculated using the FIFO (first-in, first-out) method. Provision is made for obsolete, slow-moving or defective items where appropriate.

Financial instruments

Classification

The company holds the following financial instruments:
Short term trade and other debtors and creditors; and
Cash and bank balances.

All financial instruments are classified as basic.


Recognition and measurement

The company has chosen to apply the recognition and measurement principles in FRS102.

Financial instruments are recognised when the company becomes party to the contractual provisions of the instrument and derecognised when in the case of assets, the contractual rights to cash flows from the assets expire or substantially all the risks and rewards of ownership are transferred to another party, or in the case of liabilities, when the company’s obligations are discharged, expire or are cancelled.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including directors 0 0

3. Stocks

2024 2023
£ £
Stocks 3,640 0

4. Creditors: amounts falling due within one year

2024 2023
£ £
Bank overdrafts 0 74
Amounts owed to Group undertakings 11,820 3,720
Other creditors 1,320 1,665
13,140 5,459

5. Called-up share capital

2024 2023
£ £
Allotted, called-up and fully-paid
1,000 Class A ordinary shares of £ 1.00 each 1,000 1,000

6. Related party transactions

Transactions with owners holding a participating interest in the entity

2024 2023
£ £
Amounts owing to/(from) Jonathan Cowie Endodontics Limited 5,970 1,970
Amounts owing to/(from) Maldidenti Limited 5,850 1,750